We create products that enable companies to stand out in the market. Explore our range of high-performance plant-based formulations, and discover solutions that meet your specific needs.
Schedule a call with our team to discuss ingredient and formulation options for your products.
Itaconix produces key ingredients for new generations of safer consumer products with superior performance and sustainability.
Using our proprietary plant-based technology, Itaconix develops uniquely functional ingredients that are safer for people and the planet.
We are building a large, profitable specialty ingredient company with safer products for the low carbon economy. Our growth rate has just begun to tap the potential of the addressable market.
Itaconix has entered a new era of development toward our long-term goal of becoming a large, highly profitable, capital-efficient specialty-ingredient company.
Discover latest Itaconix news and events.
Subscribe for updates and get insights sent directly to your inbox.
2 August 2018
Itaconix plc (“Itaconix” or “the Company”)
Exercise of Options, Directors’ Dealing
& Total Voting Rights
Itaconix (AIM: ITX) announces that on 2 August 2018, Robin Cridland, Executive Director, exercised options over 682,830 ordinary shares of 1p each in the Company (“Ordinary Shares”), as detailed below, and a former employee exercised options over 66,570 Ordinary Shares.
In connection with this exercise, application has been made to the London Stock Exchange for 577,530 new Ordinary Shares to be admitted to trading on AIM (the balance of 171,870 new Ordinary Shares have been satisfied by a transfer of Ordinary Shares from the Employee Benefit Trust, which have already been admitted to trading). It is expected that admission will become effective, and that dealings in the new Ordinary Shares will commence, on or around 8 August 2018.
Following admission of the new Ordinary Shares, the Company will have 269,130,071 Ordinary Shares in issue (including shares issued as part of the fundraising, as separately announced). The total number of voting rights of the Company will be 269,130,071. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
For full release, please download full news release.
Subscribe to our blog to get insights sent directly to your inbox.
